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Abstract  
Madelung disease is a disfiguring disorder belonging to the heterogeneous group of lipomatosis. The aetiology is 
not well understood, but alcohol consumption has been regarded as of importance. The reported incidence is 
about 1 in 25,000 inhabitants. We reviewed our files of the last ten years and identified eight adult patients with an 
equal gender distribution. Their age was between 60 and 85 years of life. Comorbidities are frequent. Clinical 
presentation may vary. Surgical treatment is reported and discussed. Both cold steel surgery and tumescent 
liposuction have their place in treatment.  
Introduction 
 
Madelung’s disease (MD) is a rare disorder of 
adipose tissue, characterised by disfiguring massive 
non-capsulated adipose tissue proliferations in the 
neck the shoulder, and the arms. It may be associated 
with gynecomastia or lipomastia nearly one-third of 
patients. The age peak is between 30 to 60 years of 
age with a male to female-ration of 15:1 to 30:1. The 
incidence is about one affected person in 25,000 
inhabitants. Most cases are sporadic patients [1, 2]. 
The aetiology of MD is not well understood. 
Since 86 to > 95% of patients report chronic alcohol 
consumption, secondary metabolic effect may be of 
importance [2, 3]. Alcohol can induce abnormalities in 
the catecholamine-adipose tissue interactions. 
Adrenergic lipolysis becomes impaired and may result 
in excessive adipose tissue. Furthermore, a reduction 
of mitochondrial enzymes and increased adipose 
tissue lipoprotein-lipase activity have been reported 
[4]. 
Adipocytes in MD seem to be closer to brown 
adipocytes than to white adipocytes according to 
ultrastructural investigations. In culture, pre-
adipocytes of MD develop large mitochondria with 
parallel cristae and show multi-vacuolar lipid deposits 
[5]. Investigations on cultured pre-adipocytes 
demonstrated synthesis of inner mitochondrial 
membrane protein UCP-1, which is a selective marker 
of brown adipose tissue (BAT) [6]. There are more 
arguments supporting MD as a disease of BAT: 
uncoupling protein-1 mRNA (selective BAT marker), 
and adipocyte fatty-acid protein-2 (a selective marker 
of BAT and immature adipocytes) have been 
observed in patients with MD in affected adipose 
tissue [4]. 
Figure 1: Madelung’s disease with major disfigurement (Case 1). (a) 
Massive enlargement of subcutaneous adipose tissue under the 
chin; (b) Severe gynecomastia 
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Comparing affected and non-affected 
adipocytes of patients with MD disclosed not 
differences in their surface marker profile. However, 
adipose tissue-derived stem cells had a higher 
proliferative activity. There were marked changes in 
the genetic profile for proliferation control, 
mitochondria, and hormonal regulation demonstrated 
by polymerase chain reaction (PCR) arrays [7]. 
MD patients show multiple comorbidities, 
such as hepatic disease (60%), metabolic syndrome 
(40%), chronic obstructive pulmonary disease (COPD; 
23%), hypothyroidism (10%), malignant tumors of the 
upper airways (rarely), and chronic alcohol 
consumption (> 95%) [2]. 
Figure 2: Moderate growth of adipose tissue of the neck in 
Madelung’s disease with development of multiple telangiectasias 
(Case 2) 
 
MD must be differentiated from Cushing 
syndrome and syndromic lipomatosis types of the 
head and neck region such as Familial Multiple 
Lipomatosis (FML), Encephalo-Cranio-Cutaneous 
Lipomatosis (ECCL), Congenital Infiltrating 
Lipomatosis of the Face (CIL-F), and Nasopalpebral 
Lipoma-Coloboma Syndrome (NLCS) [8, 9]. 
 
Figure 3: Improvement of Madelung’s disease by tumescent 
liposuction (Case 3). Before treatment (a, b) and after liposuction (c, 
d) 
 
 
Patients and Methods 
 
We searched our files for patients with MD 
seen at the Department of Dermatology and 
Allergology during 2007 to 2017, their clinical 
presentation, comorbidities, and three cases of 
surgical treatment. 
 
 
Results 
 
We identified eight adult patients with MD, 
four males and four females. Most patients had 
significant metabolic comorbidities. Two underwent 
bypass surgery after myocardial infarction; two 
suffered from renal insufficiency. The demographics 
and co-morbidities are summarised in Table 1 and 
Figures 1 - 8.  
Table 1: Demographics, clinical findings, and comorbidities in 
MD 
Patient Age 
(years) 
Gender Affected areas Co-morbidities 
1 75 Male 
Neck, shoulders, 
gynecomastia 
Hepatocellular carcinoma, 
alcoholic liver cirrhosis, 
compensated renal 
insufficiency 
2 67 Male Neck Hypertension 
3 68 Male 
Neck, shoulders, 
upper arms, 
gynecomastia 
Metabolic syndrome, 
myocardial infarction with 
bypass surgery, gonarthrosis 
4 60 Female Neck, shoulders Cervical spine syndrome, 
5 84 Female 
Neck, upper 
back 
bullous pemphigoid, 
myocardial infarction with 
bypass surgery, diabetes 
mellitus type II, arterial 
hypertension, osteoporosis 
6 66 Female 
Neck, shoulders, 
arms, lipomastia 
Cervical spine syndrome 
7 54 Male 
Neck and upper 
back 
Arterial hypertension, 
hypothyreosis, pulmonary 
fibrosis 
8 79 Female Neck, shoulders 
Renal nephrectomy after 
renal cell carcinoma, chronic 
anaemia, chronic renal 
insufficiency, arterial 
hypertension, 
cholecystolithiasis, knee-
TEP-surgery 
 
 
Surgical treatment 
Case 1 (Fig. 3) 
A 68-year-old male patient presented with 
symmetrical progressive lipomatosis of MD-type. He 
suffered from impairment of neck mobility and pain 
sensations. Therefore, he wanted treatment for the 
neck region. 
His medical history was positive for arterial 
hypertension, hyperlipidemia, bypass surgery after 
myocardial infarction 2013 with oral anticoagulation, 
and gonarthrosis of the right knee.  
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Figure 4: Moderate growth of subcutaneous adipose tissue with 
some telangiectasias (Case 4) 
 
 
On examination, there were massive 
disfiguring adipose tissue deposits on neck, 
shoulders, arms and gynecomastia. The largest neck 
circumference was 50 cm. 
 
 
Figure 5: Massive tumor-like swelling of the neck (Case 5) with 
obvious telangiectasias (a). (b) Operation situs demonstrates non-
encapsulated subcutaneous adipose tissue. (c) Resection 
specimen with massive enlarged adipocytes. (d) Two days after 
surgery 
 
Laboratory investigations revealed the 
following pathologic parameters: GGT 3.45 µkat/l, 
(normal range <1), CRP 15.4 mg/l (< 5), creatinin 
111µmol/l (< 90). 
Histology: the Diffuse non-septal proliferation 
of adult enlarged mono vacuolar adipocytes with 
infiltration of adjacent structures.  
Treatment and Course: He had a lipectomy in 
a plastic surgical department six years ago that 
relapsed. We performed two sessions of tumescent 
liposuction. The total amount of lipoaspiration was 600 
ml. The procedures were well tolerated. After the 
second liposuction, he developed a symptomatic met-
hemoglobinemia that was treated by intravenous 
injection of toluidine blue solution.  
 
Figure 6: Pseudo-athletic appearance in Madelung’s disease (Case 
6) 
 
 
Case 2 (Fig. 7) 
A 54-year-old male patient presented with 
longstanding, progressive subcutaneous, symmetrical 
adipose tissue deposits on the neck and upper back. 
He had a relapse after lipectomy. 
 
Figure 7: Fibrotic Madelung’s disease with dynamic growth (a and 
b), relapse after lipectomy; Stepwise improvement by tumescent 
liposuction from (c, d) to (e, f) 
 
 
Treatment and course: We treated him in 
2014 by two tumescent liposuction sessions. Although 
the lipoaspirate was only 500 ml, he reported on 
significant improvement of pain sensations and 
mobility. After two years, he experienced a partial 
relapse that was treated again by tumescent 
liposuction with good functional results (lipoaspirate 
200 ml).  
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Figure 8: Massive disfigurement of the pseudo-athletic type of 
Madelung’s disease (Case 8) 
 
 
 
Case 3 (Fig. 5) 
An 83-year-old female patient presented with 
large disfiguring lipoma-like subcutaneous masses of 
the neck region. We decided to perform combined 
lipectomy and dermato- lipectomy in general 
anaesthesia. Healing was unremarkable. The patient 
was satisfied by the functional and esthetic outcome. 
There was no relapse in the following 12 months. 
 
  
Discussion 
 
MD can lead to severe clinical complications, 
such as mediastinal syndrome, tracheobronchial 
obstruction, dysphagia, dysphonia, limited mobility of 
the neck, and somatic and autonomic neuropathies 
[6]. Such complications are an indication to surgical 
treatment [2, 10]. 
In the past, the only available treatment was 
open surgery [11]. Open surgery is characterised by a 
high rate of complications, mostly due to the severe 
comorbidities in MD patients. In a large series of 59 
MD patients, complications by surgery (lipectomy/ 
dermato- lipectomy) were observed in 17.8%. 
However, the authors preferred surgery in advanced 
cases [4]. 
Since relapses occur frequently, less invasive 
techniques were developed – either as adjuvant 
treatment or as a substitute for extensive classical 
surgery such as injection lipolysis and tumescent 
liposuction [12-14]. Injection lipolysis, however, 
causes fibrosis and adhesions which prohibit the use 
of liposuction in the case of recurrence and possibly 
complicates lipectomy surgery as well. It is therefore 
not considered as an ideal treatment for MD [15].  
Tumescent liposuction is an established 
technique not only for esthetic procedures but a 
variety of medical conditions. It offers a combination of 
adipose tissue removal and skin tightening [16].  
Constandinidis et al. (2003) used a combined 
lipectomy and liposuction in 11 patients with MD. They 
started with lipectomy in the first place followed by 
liposuction in a second “course with liposuction” being 
done at a second session. Their mean follow-up was 
2.7 years. Nine of 11 patients were satisfied with the 
esthetic outcome. Two relapses after 1.5 years and 
two years were observed [17].  
In one study seven MD patients were treated 
by liposuction successfully. Mean follow-up of 18 
months revealed a high patient satisfaction with the 
outcome of the procedure [18].  
We report on ten adult patients with MD. The 
clinical presentation can vary widely concerning the 
areas involved and the degree of disfigurement and 
functional impairment. Both the clinical features of MD 
and the frequent occurrence of comorbidities has an 
impact on treatment options. In case 1, lipectomy had 
been performed before the patient present to our 
department, but there was a significant relapse. In this 
patient as well as in the more limited type seen in 
case 2, liposuction in tumescent anaesthesia was a 
useful and safe procedure leading to minor down-time 
without extensive scars. In more advanced situations, 
lipectomy and dermato- lipectomy may be used in the 
first place as demonstrated in case 3. Surgical 
approaches are the only treatment options with a 
significant improvement of MD, often with improved 
functionality and satisfying esthetic outcome. Although 
alcohol abuse is a common pathology, there is no 
scientific proof for reduced risk of progression and 
relapses if the patient stops alcohol consumption. 
Nevertheless, comorbidities need to be considered for 
an optimal long-term outcome of patients with MD. 
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